human rtk phosphorylation antibody array c1 kit (RayBiotech inc)
Structured Review

Human Rtk Phosphorylation Antibody Array C1 Kit, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+phosphorylated+rtk+array+kit/human+rtk+phosphorylation+antibody+array/pmc09241294-287-12-19
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Ceritinib is a novel triple negative breast cancer therapeutic agent"
Article Title: Ceritinib is a novel triple negative breast cancer therapeutic agent
Journal: Molecular Cancer
doi: 10.1186/s12943-022-01601-0
Figure Legend Snippet: ACK1 is a major Ceritinib target in MDA-MB 453. ( A ) The levels of phosphorylated tyrosine kinases in a panel of 73 RTKs were analyzed by a human RTK Phosphorylation Antibody Array C1 Kit (RayBiotech) after MDA-MB 453 cells were treated with 10 μM ceritinib, DMSO was used as control. The positive dot#1,#2,#3 are all controlled amount of biotinylated antibody, which is consistent from array to array. As such, the intensity of these Positive Control signals serves much like housekeeping proteins. ( B ) The densitometric values of phospho-RTKs were determined by an image lab software (Bio-Rad). The relative intensities of the duplicated spots were normalized to positive control 1 spots. Values represent the mean of duplicate spots for each protein after normalization. ( C ) AR and ACK1 were determined by WB assay in human breast cancer cell lines and ( D ) in human breast cancer tissues
Techniques Used: Ab Array, Positive Control, Software

